United States securities and exchange commission logo





                           September 21, 2021

       Eric Newlan
       Secretary, Director & Vice President
       Black Bird Biotech, Inc.
       3505 Yucca Drive, Suite 104
       Flower Mound, Texas 75028

                                                        Re: Black Bird Biotech,
Inc.
                                                            Post-Qualification
Amendment No. 1 to Form 1-A
                                                            Filed September 16,
2021
                                                            File No. 024-11621

       Dear Mr. Newlan:

                                                        This is to advise you
that we do not intend to review your amendment.

               We will consider qualifying your offering statement at your
request. If a participant in
       your offering is required to clear its compensation arrangements with
FINRA, please have
       FINRA advise us that it has no objections to the compensation
arrangements prior to
       qualification.

               We remind you that the company and its management are
responsible for the accuracy
       and adequacy of their disclosures, notwithstanding any review, comments,
action or absence of
       action by the staff.

                                                        Please contact Gregory
Herbers at 202-551-8028 with any questions.





                           Sincerely,


                           Division of Corporation Finance

                           Office of Manufacturing